Advances in novel anti-HIV-1 drugs and drug candidates: 2005-2008
Zheng, P-rong.; Xue, H.; Xiao, Z-yan.; Liu, G.
Yao Xue Xue Bao 45(2): 154-164
2010
ISSN/ISBN: 0513-4870 PMID: 21351426 Document Number: 640483
HIV and AIDS remain as the crucial global health concern, therefore, research and development of novel anti-HIV-1 chemical therapeutics is still of paramount significance, which may be illuminated by cases of successful marketed drugs. Herein, we document the discovery and biological profile of new anti-HIV-1 drugs approved by FDA between 2005 and 2008 and some drug candidates are also discussed.
Document emailed within 1 workday
Related Documents
Kumar, S.; Rao, P.S.S.; Earla, R.; Kumar, A. 2015: Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems Expert Opinion on Drug Metabolism and Toxicology 11(3): 343-355Zhang, J.; Li, H.-F.; Fan, W.; Liu, Z.; Man, S.-L.; Si, S.-Y.; Gao, W.-Y. 2014: Regularity of drugs compatibility of anti-hepatoma traditional Chinese medicine ancient prescriptions and risk evaluation of anti-hepatoma new drug research and development Zhongguo Zhong Yao Za Zhi 39(19): 3870-3875
Guo, Z.-r. 2008: Strategy of molecular drug design: hits, leads and drug candidates Yao Xue Xue Bao 43(9): 898-904
Fialová, P.; Vlcek, J. 2004: The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs Vnitrni Lekarstvi 50(11): 858-866
Ehrlich, G. 1983: Primary drug therapy: aspirin vs. the nonsteroidal anti-inflammatory drugs Postgraduate Medicine Spec No: 9-17
Chuchottaworn, C.; Saipan, B.; Kittisup, C.; Cheewakul, K. 2012: Adverse drug reactions and outcome of short course anti-tuberculosis drugs between single daily dose and split drug dose (BID) in pulmonary tuberculosis Journal of the Medical Association of Thailand 95(Suppl 8): S1-S5
Shah, S.J.; Bhandarkar, S.D.; Satoskar, R.S. 1984: Drug interaction between chlorpropamide and non-steroidal anti-inflammatory drugs, ibuprofen and phenylbutazone International Journal of Clinical Pharmacology Therapy and Toxicology 22(9): 470-472
Tan, W.C.; Ong, C.K.; Kang, S.C.L.; Razak, M.A. 2007: Two years review of cutaneous adverse drug reaction from first line anti-tuberculous drugs Medical Journal of Malaysia 62(2): 143-146
Zamir, Q.; Nadeem, A. 2016: Non-steroidal anti-inflammatory drugs vs. Paracetamol: drug availability, patients' preference and knowledge of toxicity Journal of Ayub Medical College Abbottabad: Jamc 28(4): 746-749
Mahadev, B.; Kumar, P.; Agarwal, S.P.; Chauhan, L.S.; Srikantaramu, N. 2005: Surveillance of drug resistance to anti-tuberculosis drugs in districts of Hoogli in West Bengal and Mayurbhanj in Orissa Indian Journal of Tuberculosis 52(1): 5-10
Wrześniok, D.; Buszman, E.; Matusiński, B. 2003: Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs Wiadomosci Lekarskie 56(7-8): 369-374
2015: New drugs and indications in 2014. Some advances this year, but many drugs are poorly evaluated, too expensive, or more dangerous than useful Prescrire International 24(159): 107-110
Pötsch, S.; Drechsler, H.; Liermann, B.; Gräslund, A.; Lassmann, G. 1994: P-Alkoxyphenols, a new class of inhibitors of mammalian R2 ribonucleotide reductase: possible candidates for antimelanotic drugs Molecular Pharmacology 45(4): 792-796
McGettigan, P.; Roderick, P.; Mahajan, R.; Kadam, A.; Pollock, A.M. 2015: Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs PLOS Medicine 12(5): E1001826; Discussion E1001826
Daud, M.Y.; Qazi, R.A.; Bashir, N. 2014: Anti-retroviral drugs compliance in intravenous and non intravenous drug abusers Journal of Ayub Medical College Abbottabad: Jamc 26(4): 437-440
Daud, M.Y.; Qazi, R.A.; Bashir, N. 2014: Anti-retroviral drugs compliance in intravenous and non intravenous drug abusers Journal of Ayub Medical College Abbottabad: Jamc 26(4): 437-440
Fukuchi, S. 1988: Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; administration of synergistic drugs for protective factors in peptic ulcer--criteria of drug selection according to clinical symptoms and administration methods Nihon Rinsho. Japanese Journal of Clinical Medicine 46(1): 119-123
Finney, N.S. 1998: Fluorescence assays for screening combinatorial libraries of drug candidates Current Opinion in Drug Discovery and Development 1(1): 98-105
Strauss, B.; Appelt, H.; Börgerding, U.; Schleef, E. 1988: Drug-induced suppression of sexual functions. A physician survey of the incidence of reported sexual effects caused by antihypertensive and anti-ulcer drugs Fortschritte der Medizin 106(4): 61-63
Nakamura, H.; Kadokawa, T.; Nakatsuji, K.; Nakamura, K. 1970: Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. I. Anti-inflammatory, analgesic and anti-pyretic activity Arzneimittel-Forschung 20(8): 1032-1046